Parenteral iron use: Possible contribution to exceeding target hemoglobin in hemodialysis patients

Keyphrases

• African American 16%
• Anemia Management 16%
• Diabetes 16%
• Dialysis Patients 16%
• End-stage Renal Disease 16%
• Erythropoiesis-stimulating Agents 50%
• Exceedance Probability 16%
• Haemoglobin Target 100%
• Hemodialysis Patients 100%
• Hemoglobin 16%
• Hemoglobin Level 50%
• Hemoglobin Value 16%
• High Probability 16%
• Iron Administration 33%
• Iron Stores 16%
• Medicaid 16%
• Medicare 33%
• Odds Ratio 16%
• Other-race 16%
• Parenteral Iron 100%
• Primary Payer 16%
• Retrospective Observational Study 16%
• Service Data 16%
• White People 16%
• Young Patients 16%

Medicine and Dentistry

• Anemia 33%
• Diabetes 33%
• End Stage Renal Disease 33%
• Hematinic 100%
• Hemodialysis 100%
• Iron Storage 33%
• Medicare 66%
• Observational Study 33%
• Odds Ratio 33%
• Prevalence 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Anemia 33%
• Antianemic Agent 100%
• End Stage Renal Disease 33%
• Hemodialysis 100%
• Observational Study 33%
• Prevalence 33%